Mirae Asset Global Investments Co., Ltd. Zai Lab LTD Transaction History

Mirae Asset Global Investments Co., Ltd.

$24 Billion
Q4 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Zai Lab LTD stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,603 shares of ZLAB stock, worth $126,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,603

Previous 4,517 1.9%

Holding current value

$126,720

Previous $109,000 10.09%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	BUY	$24.61 - $33.18 $2,116 - $2,853	86 Added 1.9%	4,603 $120,000
Q3 2024 Oct 23, 2024	SELL	$16.25 - $24.14 $1.34 Million - $1.99 Million	-82,387 Reduced 94.8%	4,517 $109,000
Q2 2024 Jul 30, 2024	SELL	$13.72 - $21.55 $238,426 - $374,495	-17,378 Reduced 16.66%	86,904 $1.51 Million
Q1 2024 May 01, 2024	SELL	$15.95 - $26.8 $161,669 - $271,644	-10,136 Reduced 8.86%	104,282 $1.67 Million
Q4 2023 Jan 24, 2024	SELL	$22.97 - $30.58 $165,590 - $220,451	-7,209 Reduced 5.93%	114,418 $3.13 Million
Q3 2023 Oct 26, 2023	BUY	$22.72 - $31.49 $195,164 - $270,499	8,590 Added 7.6%	121,627 $2.96 Million
Q2 2023 Aug 10, 2023	SELL	$25.3 - $39.67 $462,914 - $725,841	-18,297 Reduced 13.93%	113,037 $3.13 Million
Q1 2023 May 04, 2023	SELL	$30.21 - $48.1 $1.27 Million - $2.02 Million	-42,027 Reduced 24.24%	131,334 $4.37 Million
Q4 2022 Feb 09, 2023	BUY	$22.28 - $38.71 $49,907 - $86,710	2,240 Added 1.31%	173,361 $5.32 Million
Q3 2022 Nov 10, 2022	BUY	$34.2 - $51.69 $448,430 - $677,759	13,112 Added 8.3%	171,121 $5.85 Million
Q2 2022 Jul 26, 2022	SELL	$23.14 - $49.68 $235,819 - $506,288	-10,191 Reduced 6.06%	158,009 $5.48 Million
Q1 2022 May 10, 2022	BUY	$27.77 - $64.4 $981,419 - $2.28 Million	35,341 Added 26.6%	168,200 $7.4 Million
Q4 2021 Feb 08, 2022	SELL	$54.9 - $105.21 $1.3 Million - $2.48 Million	-23,604 Reduced 15.09%	132,859 $8.35 Million
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $3.24 Million - $5.5 Million	-30,813 Reduced 16.45%	156,463 $16.5 Million
Q2 2021 Aug 11, 2021	BUY	$125.11 - $180.0 $816,592 - $1.17 Million	6,527 Added 3.61%	187,276 $33.1 Million
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $7.14 Million - $10.8 Million	56,512 Added 45.49%	180,749 $24.1 Million
Q4 2020 Feb 10, 2021	BUY	$81.94 - $135.34 $700,095 - $1.16 Million	8,544 Added 7.39%	124,237 $16.8 Million
Q3 2020 Nov 12, 2020	BUY	$73.3 - $89.48 $8.06 Million - $9.84 Million	109,950 Added 1914.5%	115,693 $9.62 Million
Q2 2020 Aug 11, 2020	BUY	$48.82 - $82.53 $38,372 - $64,868	786 Added 15.86%	5,743 $472,000
Q1 2020 May 12, 2020	BUY	$39.1 - $62.9 $193,818 - $311,795	4,957 New	4,957 $255,000

Others Institutions Holding ZLAB

# of Institutions

127

Shares Held

49.6M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.7B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Zai Lab LTD Transaction History